Thai Rayon Past Earnings Performance
Past criteria checks 0/6
Thai Rayon's earnings have been declining at an average annual rate of -3.7%, while the Chemicals industry saw earnings growing at 7.5% annually. Revenues have been growing at an average rate of 4.9% per year.
Key information
-3.7%
Earnings growth rate
-3.7%
EPS growth rate
| Chemicals Industry Growth | 8.0% |
| Revenue growth rate | 4.9% |
| Return on equity | -4.9% |
| Net Margin | -16.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Thai Rayon makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 9,481 | -1,586 | 731 | 0 |
| 31 Mar 24 | 9,339 | -1,852 | 677 | 0 |
| 31 Dec 23 | 8,928 | 1,259 | 585 | 0 |
| 30 Sep 23 | 7,618 | -584 | 563 | 0 |
| 30 Jun 23 | 7,519 | 154 | 657 | 0 |
| 31 Mar 23 | 8,324 | 683 | 971 | 0 |
| 31 Dec 22 | 9,633 | 1,369 | 1,370 | 0 |
| 30 Sep 22 | 11,235 | 3,247 | 1,778 | 0 |
| 30 Jun 22 | 11,288 | 3,301 | 1,892 | 0 |
| 31 Mar 22 | 10,559 | 3,504 | 1,734 | 0 |
| 31 Dec 21 | 9,614 | 3,628 | 1,515 | 0 |
| 30 Sep 21 | 8,222 | 3,033 | 1,169 | 0 |
| 30 Jun 21 | 7,203 | 1,980 | 948 | 0 |
| 31 Mar 21 | 6,056 | 89 | 758 | 0 |
| 31 Dec 20 | 5,745 | 53 | 627 | 0 |
| 30 Sep 20 | 5,988 | 86 | 602 | 0 |
| 30 Jun 20 | 6,671 | -225 | 603 | 0 |
| 31 Mar 20 | 7,381 | 189 | 620 | 0 |
| 31 Dec 19 | 7,899 | -314 | 611 | 0 |
| 30 Sep 19 | 8,622 | 95 | 610 | 0 |
| 30 Jun 19 | 9,058 | 649 | 617 | 0 |
| 31 Mar 19 | 9,449 | 1,577 | 609 | 0 |
| 31 Dec 18 | 9,764 | 1,703 | 640 | 0 |
| 30 Sep 18 | 9,768 | 1,840 | 614 | 0 |
| 30 Jun 18 | 9,728 | 2,026 | 599 | 0 |
| 31 Mar 18 | 10,094 | 2,128 | 627 | 0 |
| 31 Dec 17 | 9,505 | 2,402 | 563 | 0 |
| 30 Sep 17 | 9,238 | 2,539 | 532 | 0 |
| 30 Jun 17 | 9,491 | 2,560 | 516 | 0 |
| 31 Mar 17 | 9,130 | 2,325 | 463 | 0 |
| 31 Dec 16 | 9,681 | 1,942 | 448 | 0 |
| 30 Sep 16 | 10,027 | 1,980 | 455 | 0 |
| 30 Jun 16 | 9,507 | 1,721 | 442 | 0 |
| 31 Mar 16 | 9,287 | 1,386 | 444 | 0 |
| 31 Dec 15 | 8,794 | 683 | 462 | 0 |
| 30 Sep 15 | 8,305 | -219 | 485 | 0 |
| 30 Jun 15 | 8,129 | -688 | 504 | 0 |
| 31 Mar 15 | 7,821 | -1,295 | 511 | 0 |
| 31 Dec 14 | 8,228 | -1,338 | 777 | 0 |
| 30 Sep 14 | 8,200 | -1,317 | 1,065 | 0 |
| 30 Jun 14 | 10,112 | -1,144 | 1,445 | 0 |
| 31 Mar 14 | 11,856 | -967 | 1,759 | 0 |
| 31 Dec 13 | 13,178 | -704 | 1,354 | 0 |
Quality Earnings: TR is currently unprofitable.
Growing Profit Margin: TR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TR is unprofitable, and losses have increased over the past 5 years at a rate of 3.7% per year.
Accelerating Growth: Unable to compare TR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TR is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (37%).
Return on Equity
High ROE: TR has a negative Return on Equity (-4.85%), as it is currently unprofitable.